To investigate the underlying mechanisms by which iron promotes the occurrence of PD, we analyzed the activity of LRRK2, which is likely central in the pathogenesis of PD, in SH-SY5Y cells treated with 6-OHDA and FAC. Here, LRRK2 is linked to Parkinson disease.